Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Return on Invested Capital: 2021-2023

Historic Return on Invested Capital for Oncology Institute (TOI) over the last 3 years, with FY2023 value amounting to 0.44%.

  • Oncology Institute's Return on Invested Capital changed N/A to 0.63% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.63%, marking a year-over-year change of. This contributed to the annual value of 0.44% for FY2023, which is 13300.0% down from last year.
  • Per Oncology Institute's latest filing, its Return on Invested Capital stood at 0.44% for FY2023, which was down 13300.0% from 0.89% recorded in FY2022.
  • In the past 5 years, Oncology Institute's Return on Invested Capital ranged from a high of 0.89% in FY2022 and a low of 0.63% during FY2021
  • In the last 3 years, Oncology Institute's Return on Invested Capital had a median value of 0.44% in 2023 and averaged 0.06%.
  • In the last 5 years, Oncology Institute's Return on Invested Capital soared by 15200bps in 2022 and then plummeted by -13300bps in 2023.
  • Oncology Institute's Return on Invested Capital (Annual) stood at 0.63% in 2021, then skyrocketed by 242bps to 0.89% in 2022, then tumbled by -150bps to 0.44% in 2023.
  • Its Return on Invested Capital was 0.44% in FY2023, compared to 0.89% in FY2022 and 0.63% in FY2021.